NCT00691769 is a clinical trial in Central Centrifugal Scarring Alopecia, sponsored by Wake Forest University.

Who is sponsoring NCT00691769?

NCT00691769 is sponsored by Wake Forest University.

What condition does NCT00691769 study?

NCT00691769 studies Central Centrifugal Scarring Alopecia, Lichen Planopilaris, Discoid Lupus Erythematosus.

Is NCT00691769 still recruiting?

NCT00691769 is currently completed. Last updated 6 July 2018.

Last reviewed 2018-07-06 · How we verify

NCT00691769

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia

Completed Last updated 6 July 2018

What this trial tests

trial in Central Centrifugal Scarring Alopecia in 8 participants. Completed in 26 November 2012.

Timeline

26 April 2006

Primary endpoint
26 November 2012

26 November 2012

Quick facts

Lead sponsor	Wake Forest University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	8
Start date	26 April 2006
Primary completion	26 November 2012
Estimated completion	26 November 2012
Sites	1 location across United States

Conditions studied

Central Centrifugal Scarring Alopecia — all drugs for Central Centrifugal Scarring Alopecia →
Lichen Planopilaris — all drugs for Lichen Planopilaris →
Discoid Lupus Erythematosus — all drugs for Discoid Lupus Erythematosus →

Sponsor

Wake Forest University

Who can join

30 and older, female only, with Central Centrifugal Scarring Alopecia or Lichen Planopilaris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Wake Forest University trials

Trials by the same sponsor.

NCT06623669 — A Mobile Intervention to Reduce Pain and Improve Health-III · Phase 2 · recruiting
NCT05946044 — The Osteoarthritis Prevention Study · NA · recruiting
NCT05596474 — Effect of Beet-root Juice and PBM Treatments on Muscle Fatigue · NA · unknown
NCT05392621 — Stress Management in College Students · NA · completed
NCT04946344 — The Cherokee Study: Cherokee Health for Elderly Residents With Osteoarthritis of the Knee · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00691769 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wake Forest University
Last refreshed: 6 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00691769.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing